Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 21.12.2021.

#stocks
#biotech
#Physician
#PrimaryCare
#researchers
#cancer
#hope
#AI

Healthcare

@JNap5C shared
On Dec 17, 2021
RT @herbgreenberg: My latest - A Day at the Races - Betting on Biotech, starring @JNap5C (if you were wondering where he is now!), plus a brief appearance by the @hardmoneypod and thanks to @KailashConcepts, for a quick chart. $LQDA, CMRX, CRDF https://t.co/8WDOEcdghq
Open
A Day at the Races – Betting on Biotech

A Day at the Races – Betting on Biotech

 Originally published at Empire Financial Research.  ► Investing in biotechnology is like going to the racetrack.

@kevinmd shared
On Dec 15, 2021
Leaving clinical medicine without regrets https://t.co/wGJhJNlLuE #Physician #PrimaryCare via @kevinmd
Open
Leaving clinical medicine without regrets

Leaving clinical medicine without regrets

It took a few weeks before I could wake up on a Saturday without the ever-present Epic dread hanging over me. The thought — a very probable thought — that I was missing something important, ...

@SWLifeSciences shared
On Dec 20, 2021
Analyst Says Regeneron Could Be 'Biotech Champion': https://t.co/8fLx9All5X Oppenheimer has an Outperform rating and an $825 per share price target on Regeneron. $REGN #biotech #stocks @Regeneron https://t.co/wqlEx71XDP
Open
Analyst Says Regeneron Could Be 'Biotech Champion' Research Report

Analyst Says Regeneron Could Be 'Biotech Champion' Research Report

Regeneron Pharmaceuticals Inc.'s stock was up 36% in 2021 while the NASDAQ Biotechnology Index remained flat, an Oppenheimer analyst noted.

@EUScienceInnov shared
On Dec 19, 2021
🔵🎧What about research on #cancer?"There is a lot of #hope" 🙌 says @CaroffMartine, winner of the 2019 EU Prize for Women Innovators. "There is an amazing progress that has been made and lots of #researchers are bringing 🆕 molecules to be tested!" 👇 https://t.co/IQBlLKiIhB
Open
S02/E06: Cancer mission… curing more, curing better

S02/E06: Cancer mission… curing more, curing better

In this final episode of the season two, Jennifer Baker meetsDrMartine Caroffa French scientist, mentor and entrepreneur who founded two equally impressive biotech businesses. Her first, ...

@SWLifeSciences shared
On Dec 20, 2021
BTIG Analyst Highlights Top Picks in Biotech for 2022: https://t.co/wM0dXysGh0 $ALDX $STOK $SQZ $PLRX #biotech #stocks @AldeyraALDX @SQZBiotech @PliantRX @StokeTx https://t.co/fuGjcyh2PS
Open
Analyst Highlights Top Picks in Biotech for 2022 Research Report

Analyst Highlights Top Picks in Biotech for 2022 Research Report

Aldeyra Therapeutics and SQZ Biotechnologies have advantages that their specific approaches allow, noted a BTIG report.

@matthewherper shared
On Dec 15, 2021
This virtual event, on diversity in orthopedic surgery, was surprisingly fascinating thanks to skilled moderation by @SciFleur. Have a look -- it's in front of the paywall. https://t.co/X3UrmDlqd7
Open
STAT+ Conversation: The Whitest Medical Specialty

STAT+ Conversation: The Whitest Medical Specialty

STAT's Nicholas St. Fleur sits down with Dr. Gabriella Ode to discuss why orthopedic surgery remained the least diverse field of medicine.

@DeloitteHealth shared
On Dec 15, 2021
There is a significant opportunity for biopharma companies to explore how #AI can address some persistent marketing challenges. Find out how AI can help drive biopharma marketing ROI. https://t.co/rj9fmdLlfz
Open
How AI Can Help Drive Biopharma Marketing ROI

How AI Can Help Drive Biopharma Marketing ROI

Pharmaceutical and biotech marketers polled in the latest “CMO Survey” report low current investment in AI and machine learning as part of their marketing analytics capabilities. The ...

@matthewherper shared
On Dec 14, 2021
“I’ve lost more sleep worrying about answering questions about Omicron than over Omicron itself.” https://t.co/G8L71T7PRN
Open
Leading Covid-19 experts on the questions they want answered about Omicron

Leading Covid-19 experts on the questions they want answered about Omicron

“There’s still a lot that we don’t have answers to yet" about Omicron, said Céline Gounder, an infectious disease specialist.